Literature DB >> 18413302

Fetal radiation dose from CT pulmonary angiography in late pregnancy: a phantom study.

S K Doshi1, I S Negus, J M Oduko.   

Abstract

Pulmonary embolism (PE) is the leading direct cause of maternal mortality in the UK. Accurate diagnosis is important but, even though CT pulmonary angiography (CTPA) is the recommended imaging modality for PE in the general population, there is limited guidance for pregnant patients. Knowledge of the radiation doses to both the mother and the fetus is therefore important in the justification of CTPA in this situation. Dose measurements were made on three helical CT scanners, with an anthropomorphic phantom representing the chest and abdomen in late gestation. Estimated fetal doses from CT scans of the maternal chest were in the range of 60-230 microGy. Fetal dose reduction strategies (mA modulation, shielding with a lead coat, and a 5 cm shorter scan length) were investigated. These reduced the fetal dose by 10%, 35% and 56%, respectively. Fetal doses from a scan projection radiograph (SPR) of the maternal chest were insignificant when compared with the dose from a CT scan. However, if the SPR was not stopped before the "fetus" was directly irradiated, the dose measured on one scanner was 20 microGy.

Entities:  

Mesh:

Year:  2008        PMID: 18413302     DOI: 10.1259/bjr/22775594

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  11 in total

1.  Effect of antenatal iodinated contrast agent on neonatal thyroid function.

Authors:  S Rajaram; C E Exley; F Fairlie; S Matthews
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  Organ and effective dose reduction in adult chest CT using abdominal lead shielding.

Authors:  G R Iball; D S Brettle
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

Review 3.  Risks to the fetus from diagnostic imaging during pregnancy: review and proposal of a clinical protocol.

Authors:  Mafalda Gomes; Alexandra Matias; Filipe Macedo
Journal:  Pediatr Radiol       Date:  2015-08-14

4.  Radiation doses for pregnant women in the late pregnancy undergoing fetal-computed tomography: a comparison of dosimetry and Monte Carlo simulations.

Authors:  Yuta Matsunaga; Ai Kawaguchi; Masanao Kobayashi; Shigetaka Suzuki; Shoichi Suzuki; Koichi Chida
Journal:  Radiol Phys Technol       Date:  2016-09-19

Review 5.  Imaging for the exclusion of pulmonary embolism in pregnancy.

Authors:  Thijs E van Mens; Luuk Jj Scheres; Paulien G de Jong; Mariska Mg Leeflang; Mathilde Nijkeuter; Saskia Middeldorp
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

Review 6.  Pulmonary embolism in pregnancy.

Authors:  E Conti; L Zezza; E Ralli; C Comito; L Sada; J Passerini; D Caserta; S Rubattu; C Autore; M Moscarini; M Volpe
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

7.  Imaging for suspected pulmonary embolism in pregnancy-what about the fetal dose? A comprehensive review of the literature.

Authors:  Tilo Niemann; Guillaume Nicolas; Hans W Roser; Jan Müller-Brand; Georg Bongartz
Journal:  Insights Imaging       Date:  2010-10-02

8.  Foetal radiation dose and risk from diagnostic radiology procedures: a multinational study.

Authors:  Ernest K Osei; Johnson Darko
Journal:  ISRN Radiol       Date:  2012-09-25

9.  TO USE OR NOT USE PATIENT SHIELDING ON PREGNANT WOMEN UNDERGOING CT PULMONARY ANGIOGRAPHY: A PHANTOM STUDY.

Authors:  Dino Begano; Marcus Söderberg; Anetta Bolejko
Journal:  Radiat Prot Dosimetry       Date:  2020-07-24       Impact factor: 0.972

10.  Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a systematic review and meta-analysis.

Authors:  Cécile Tromeur; Liselotte M van der Pol; Pierre-Yves Le Roux; Yvonne Ende-Verhaar; Pierre-Yves Salaun; Christophe Leroyer; Francis Couturaud; Lucia J M Kroft; Menno V Huisman; Frederikus A Klok
Journal:  Haematologica       Date:  2018-08-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.